Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 816-820

  Joachims, Michelle L ^a,d   Marble, Patrick ^a   Knott Craig, Christopher ^b   Pastuszko, Peter ^b   Blackburn, Michael R ^c   Thompson, Linda F ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d MS 29 ^*  (United States)

Author keywords

ADA deficiency; Apoptosis; Deoxynucleoside kinases; Human thymocyte development

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE KINASE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE KINASE;

ADENOSINE DEAMINASE DEFICIENCY; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; THYMOCYTE;

ADENOSINE DEAMINASE; ADENOSINE KINASE; ANTIGENS, CD34; APOPTOSIS; CELLS, CULTURED; DEOXYADENINE NUCLEOTIDES; DEOXYCYTIDINE KINASE; ENZYME INHIBITORS; HUMANS; INFANT; PRECURSOR CELLS, T-LYMPHOID; THYMUS GLAND;

EID: 46649121858     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802146270     Document Type: Conference Paper

References (11)

1. Hershfield, M.S.; Mitchell, B.S. Immunodeficiency Diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed., eds. C.R. Scriver, W.S. Sly, B. Childs, A.L. Beaudet, D. Valle, K. Kinzler, B. Vogelstein, McGraw-Hill, New York, 2001, vol. 2, chap. 109.
2. Blackburn, M.R.; Kellems, R.E. Adenosine deaminase deficiency: Metabolic Basis of immune deficiency and pulmonary inflammation. Adv. Immunol. 2005, 86, 1-41.
3. Carson, D.A.; Wasson, D.B.; Lakow, E.; Kamatani, N. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase. Proc. Natl. Acad. Sci. USA 1982, 79, 3848-3852.
4. Mitchell, B.S.; Mejias, E.; Daddona, P.E.; Kelley, W.N. Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T cells. Proc. Natl. Acad. Sci. USA 1978, 75, 5011-5014.
5. Hershfield, M.S.; Fetter, J.E.; Small, W.C.; Bagnara, A.S.; Williams, S.R.; Ullman, B.; Martin, D.W., Jr.; Wasson, D.B.; Carson, D.A. Effects of Mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells. J. Biol. Chem. 1982, 257, 6380-6386.
6. Ullman, B.; Levinson, B.B.; Hershfield, M.S.; Martin, D.W., Jr. A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells. J. Biol. Chem. 1981, 256, 848-852.
7. Thompson, L.F.; Van De Wiele, C.J.; Laurent, A.B.; Hooker, S.W.; Vaughn, J.G.; Jiang, H.; Khare, K., Kellems, R.E.; Blackburn, M.R.; Hershfield, M.S.; Resta, R. Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures. J. Clin. Invest. 2000, 106, 1149-1157.
8. Van De Wiele, C.J.; Vaughn, J.G.; Blackburn, M.R.; Ledent, C.; Jacobson, M.; Jiang, H.; Thompson, L.F. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking DATP accumulation.J. Clin. Invest. 2002, 110, 395-402.
9. Agarwal, R.P.; Spector, T.; Parks, Jr.R.E. Tight-binding inhibitors-IV. Inhibition of adenosine deaminases by various inhibitors. Biochem. Pharmacol. 1977, 26, 359-367.
10. Ugarkar, B.G.; DaRe, J.M.; Kopcho, J.J.; Browne, C.E.; III; Schanzer, J.M.; Weisner, J.B.; Erion, M.D. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J Med. Chem. 2000, 43, 2883-2893.
11. Arner, E.S.; Eriksson, S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 1995, 67, 155-186.